an experimental experience

11/18/22 at 1:53pm

Organization

Ars Technica

Author

Beth Mole

31 words

Comments

"We’re obviously not the only insulin company. But the tropes go on," he said.

You are the first to view

https://arstechnica.com/science/2022/11/eli-lilly-ceo-says-insulin-tweet-flap-probably-signals-need-to-bring-down-cost/

Create an account or login to join the discussion